High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.1M
$8,123,219
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$778,812x4
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $778,812x4 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$745,984x8
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $745,984x8 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$567,546x4
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $567,546x4 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$562,585x10
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $562,585x10 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$1,533,100Largex5
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $1,533,100Largex5 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-02-13
$695,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$547,929x21
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $547,929x21 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$1,364,387Largex5
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $1,364,387Largex5 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$1,327,675Largex12
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $1,327,675Largex12 | S | Form 4 |